全文获取类型
收费全文 | 3469360篇 |
免费 | 266423篇 |
国内免费 | 12718篇 |
专业分类
耳鼻咽喉 | 48059篇 |
儿科学 | 112150篇 |
妇产科学 | 95920篇 |
基础医学 | 500346篇 |
口腔科学 | 98532篇 |
临床医学 | 318322篇 |
内科学 | 659515篇 |
皮肤病学 | 75287篇 |
神经病学 | 273770篇 |
特种医学 | 132936篇 |
外国民族医学 | 972篇 |
外科学 | 518853篇 |
综合类 | 94698篇 |
现状与发展 | 36篇 |
一般理论 | 1302篇 |
预防医学 | 271975篇 |
眼科学 | 82355篇 |
药学 | 264452篇 |
121篇 | |
中国医学 | 12099篇 |
肿瘤学 | 186801篇 |
出版年
2019年 | 29725篇 |
2018年 | 39639篇 |
2017年 | 30703篇 |
2016年 | 33766篇 |
2015年 | 39634篇 |
2014年 | 54945篇 |
2013年 | 79564篇 |
2012年 | 109323篇 |
2011年 | 116451篇 |
2010年 | 69355篇 |
2009年 | 64862篇 |
2008年 | 107255篇 |
2007年 | 113664篇 |
2006年 | 114954篇 |
2005年 | 111977篇 |
2004年 | 106522篇 |
2003年 | 101851篇 |
2002年 | 98796篇 |
2001年 | 153432篇 |
2000年 | 158139篇 |
1999年 | 133855篇 |
1998年 | 38040篇 |
1997年 | 33637篇 |
1996年 | 33026篇 |
1995年 | 33654篇 |
1994年 | 31200篇 |
1993年 | 29110篇 |
1992年 | 106333篇 |
1991年 | 104028篇 |
1990年 | 101483篇 |
1989年 | 97952篇 |
1988年 | 90638篇 |
1987年 | 88958篇 |
1986年 | 84040篇 |
1985年 | 80928篇 |
1984年 | 60515篇 |
1983年 | 51859篇 |
1982年 | 30709篇 |
1979年 | 56757篇 |
1978年 | 40134篇 |
1977年 | 33607篇 |
1976年 | 32058篇 |
1975年 | 34287篇 |
1974年 | 41545篇 |
1973年 | 39744篇 |
1972年 | 37113篇 |
1971年 | 35046篇 |
1970年 | 32312篇 |
1969年 | 30698篇 |
1968年 | 28075篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
75.
Cody M. Lebeck Lee MD Ioannis A. Ziogas MD Rajiv Agarwal MD Sophoclis P. Alexopoulos MD Kristen K. Ciombor MD Lea K. Matsuoka MD Daniel B. Brown MD Cathy Eng MD 《Cancer》2022,128(12):2243-2257
The 5-year overall survival rate of a patient with unresectable metastatic colorectal cancer is poor at approximately 14%. Similarly, historical data on liver transplantation (LT) in those with colorectal liver metastases (CRLM) showed poor outcomes, with 5-year survival rates between 12% and 21%. More recently, limited data have shown improved outcomes in select patients with 5-year overall survival rates of approximately 60%. Despite these reported survival improvements, there is no significant improvement in disease-free survival. Given the uncertain benefit with this therapeutic approach and a renewed investigational interest, we aimed to conduct a contemporary systematic review on LT for CRLM. A systematic review of the literature was performed according to the preferred reporting items for systematic reviews and meta-analysis statement. English articles reporting on data regarding LT for CRLM were identified through the MEDLINE (via PubMed), Cochrane Library, and ClinicalTrials.gov databases (last search date: December 16th, 2021) by 2 researchers independently. A total of 58 studies (45 published and 13 ongoing) were included. Although early retrospective studies suggest the possibility that some carefully selected patients may benefit from LT, there is minimal prospective data on the topic and LT remains exploratory in the setting of CRLM. Additionally, several other challenges, such as the limited availability of deceased donor organs and defining appropriate selection criteria, remain when considering the implementation of LT for these patients. Further evidence from ongoing prospective trials is needed to determine if and to what extent there is a role for LT in patients with surgically unresectable CRLM. 相似文献
76.
Greer Hunter R. Miller Kristen Samay Sadaf Nellan Anandani Green Adam L. 《Journal of neuro-oncology》2022,159(2):301-308
Journal of Neuro-Oncology - The role of white blood cells (WBC) in the pediatric central nervous system (CNS) tumor microenvironment is incompletely defined. We hypothesized that the WBC profile in... 相似文献
77.
78.
von Heesen Maximilian Schuld Jochen Hollnder Sebastian Spiliotis Antonios E. Merscher Anna Scherber Philipp R. Igna Dorian Gbelein Gereon Glanemann Matthias 《European Surgery》2022,54(6):317-325
European Surgery - The beneficial outcomes of hepatectomy in patients with colorectal metastases have encouraged the attempts of repeated hepatectomy in patients with recurrent disease. Although... 相似文献
79.
Edwin van der Pol Joshua A. Welsh Rienk Nieuwland 《Journal of thrombosis and haemostasis》2022,20(1):245-251
The Extracellular Vesicle Flow Cytometry Working Group ( http://www.evflowcytometry.org ) is formed by members of the International Society for Extracellular Vesicles (ISEV), the International Society for Advancement of Cytometry (ISAC), and the International Society on Thrombosis and Haemostasis (ISTH). This working group of flow cytometry experts develops guidelines for best practices regarding flow cytometry detection of extracellular vesicles. To improve rigor and standardization, this working group published a framework outlining the minimal information to report about a flow cytometry experiment on extracellular vesicles (MIFlowCyt-EV) in the Journal of Extracellular Vesicles, the ISEV journal, in 2020. In parallel, an article explaining MIFlowCyt-EV was published in Cytometry Part A, one of the ISAC journals, and now will be introduced to the ISTH as an SSC Communication in the Journal of Thrombosis and Haemostasis. The goal of this SSC Communication is to explain why flow cytometry is becoming the instrument of choice to characterize single extracellular vesicles, the obstacles that have been identified and (mostly) overcome by developing procedures to calibrate flow cytometers, and the relevance of reporting minimal information to improve reliability and reproducibility of experiments in which flow cytometers are used for characterization of extracellular vesicles. 相似文献
80.
Cornelius Anna Pilger Daniel Riechardt Aline Reitemeyer Emanuel Rübsam Anne Winterhalter Sibylle Maier Anna-Karina B. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(3):957-965
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare the blood flow situation in primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PXG) using optical... 相似文献